Advertisement

Topics

ABIVAX Company Profile

10:31 EST 23rd January 2019 | BioPortfolio


News Articles [21 Associated News Articles listed on BioPortfolio]

Abivax SA (ABVX-FR): Getting a brake in -2-

DJ Abivax SA (ABVX-FR): Getting a brake in inflammation Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Abivax SA (ABVX-FR): Getting a br...

Abivax completes dosing in ABX464-101 trial for UC

Abivax has completed dosing patients in the ABX464-101 trial, a Phase lla clinical trial investigating the safety and efficacy of...Read More... The post Abivax completes dosing in ABX464-101 trial fo...

Abivax Aktie mit Kursgewinn nach News zu ABX464-Studie

Das französische Biotechunternehmen Abivax hat am Donnerstag Neuigkeiten zu den laufenden klinischen Untersuchungen der Phase II für den Medikamentenkandidaten ABX464 veröffentlicht. Das zuständig...

Abivax reports positive topline results from ABX464-101 trial for UC

Abivax has reported positive topline results from its Phase lla ABX464-101 clinical trial evaluating the safety and efficacy of ABX464...Read More... The post Abivax reports positive topline results f...

CEO Interview: Ulcerative Colitis Trial Shows Abivax's HIV Candidate Has Broader Potential

Abivax Phase IIa data for its lead asset showed impressive results in ulcerative colitis. The biotech's CEO tells Scrip trials...   

Abivax sets its course on colitis and Crohn’s

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease. Ab...

Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment

Shares of Paris-based Abivax have shot up more than 8 percent this morning after the company posted positive mid-stage results for its ulcerative colitis treatment, ABX465.

CEO Interview: Ulcerative Colitis Trial Shows Abivax's HIV Vaccine Candidate Has Broader Potential

Abivax Phase IIa data for its lead asset showed impressive results in ulcerative colitis. The biotech's CEO tells Scrip trials...   

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "ABIVAX" on BioPortfolio

We have published hundreds of ABIVAX news stories on BioPortfolio along with dozens of ABIVAX Clinical Trials and PubMed Articles about ABIVAX for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ABIVAX Companies in our database. You can also find out about relevant ABIVAX Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record